Tirzepatide's benefits extend to Kidney Disease
Tirzepatide (Mounjaro, Zepbound) shows results in weight loss and Hba1c reduction for southerners, critical to kidney disease treatment.
The list of benefits of using GLP1 Receptor Agonists continues to increase. Mounjaro and Zepbound are brand names for a peptide called Tirzepatide, which is one of the most effective GLP1s on the market today.
🍃
Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work?
Check out our quick explainer
Check out our quick explainer
The positive effects we're examining today are some of the same ones most people already know – weight loss, reductions to Hba1c, but with a new focus: Kidney Disease.
The study is tiny, but the pre and post Tirzepatide metrics speak for themselves:
The rest of this article is no longer available for free – if you'd like to read the rest of our analysis, check us out on Substack:
